Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2025-12-09 00:00:00 ET · period of report 2025-12-08 · accession 0001536368-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-09 | 2025-12-08 | ORIC | Kunkel Lori Anne | Dir | M - OptEx | $7.90 | +10.0K | 84.2K | +13% | +$79.0K |
| D | 2025-12-09 | 2025-12-08 | ORIC | Kunkel Lori Anne | Dir | M - OptEx | $0.00 | -10.0K | 15.6K | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-08 | M | A | 10,000 | $7.90 | 84,200 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-12-08 | M | D | 10,000 | $0.00 | 15,600 | D | $7.90 · — to 2034-06-11 | 10,000 Common Stock | (F1) One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) June 12, 2025 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant. |